Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000029096Phase 4Completed
Phase 4, open-label trial of levofloxacin in pulmonary infection (2 arms), sponsored by Huashan Hospital. Primary endpoints: Levofloxacin concentration in sputum, Levofloxacin concentration in bronchoalveolar lavage fluid and 3 more. Started Oct 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000029096.